Mia Hamm fronts GSK vaccine awareness effort

Share this article:
Mia Hamm fronts GSK vaccine awareness effort
Mia Hamm fronts GSK vaccine awareness effort

GlaxoSmithKline tapped soccer phenom Mia Hamm for a new vaccine awareness campaign promoting vaccines as an integral part of adult health. Hamm fronted a MedImmune/AstraZeneca flu vaccine awareness campaign last summer.

The GSK campaign, titled Give Your Health A Shot, promotes adult vaccination in general – from flu and whooping cough to hepatitis A and B, HPV and meningococcal vaccines – as a necessary part of “a healthy plan for living,” according to GSK spokesperson Amy Searfoorce.

The campaign website offers information about vaccines, including the Centers for Disease Control and Prevention (CDC) recommendation that “adults be vaccinated against up to 14 diseases.” Eight vaccines are detailed on the website, but no brand names are discussed.

The American College of Physicians (ACP), and Brad Moore, an ACP fellow, are also partners on the campaign, with Moore and Hamm appearing in a DVD available as part of a guidebook for download on the website. The 30-page guidebook (including information about vaccines, healthy living, and a checklist for patients to use in the doctor's office) and DVD was created by GSK and the ACP, with producers Conrad & Associates and Alan Weiss Productions. Hamm and Moore were both compensated for their participation – as noted on the site – but dollar amounts were not immediately available, per Searfoorce.

Hamm conducted various interviews with media outlets today, said Searfoorce, but no further events or print advertising (beyond the guidebook) is scheduled. In October, video from the DVD will run as a 30-minute televised PSA in a handful of markets, including St. Louis, San Francisco, Detroit, Atlanta and Washington DC, said Searfoorce.

GSK currently markets five vaccines for adults in the US, coinciding with the recommendations on the site, as follows:

  • Influenza: Fluarix, FluLaval
  • Human papillomavirus (HPV): Cervarix
  • Hepatitis A: Havrix
  • Hepatitis B: Engerix-B
  • Hepatitis A&B: Twinrix
  • Whooping cough (Tdap): Boostrix
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...